Peter E. Westerweel

4.4k citations

80 papers · 1.3k indexed · h-index 20

Impact in

Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
Hematology top 5%
- Chronic Myeloid Leukemia Treatments

Papers in ⓘ

Hematology 43
- Chronic Myeloid Leukemia Treatments 32
- Acute Myeloid Leukemia Research 6
Genetics 30
- Chronic Lymphocytic Leukemia Research 23

Co-authors: Marianne C. Verhaar (18 shared papers)Imo E. Hoefer (3 shared papers)Hein A. Koomans (2 shared papers)Mark‐David Levin (13 shared papers)Jan J. Cornelissen (12 shared papers)Jeroen Rouwkema (1 shared paper)Ronald H. W. M. Derksen (1 shared paper)Jan de Boer (1 shared paper)
Journals: Blood (9 papers)HemaSphere (4 papers)European Journal Of Haematology (4 papers)Research and Practice in Thrombosis and Haemostasis (3 papers)Leukemia (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Peter E. Westerweel

76 papers receiving 1.3k citations

Peers

Countries citing papers authored by Peter E. Westerweel

Since Specialization

Citations

This map shows the geographic impact of Peter E. Westerweel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Westerweel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Westerweel more than expected).

Fields of papers citing papers by Peter E. Westerweel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Westerweel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Westerweel. The network helps show where Peter E. Westerweel may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter E. Westerweel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter E. Westerweel Line = papers co-authored together Peter E. Westerweel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Use of Endothelial Progenitor Cells for Prevascularized Bone Tissue Engineering Tissue Engineering Part A ·Jeroen Rouwkema, Peter E. Westerweel, Jan de Boer, Marianne C. Verhaar, Clemens van Blitterswijk	2009	97
2	Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus Arthritis & Rheumatism ·Peter E. Westerweel, Remco K. M. A. C. Luyten, Hein A. Koomans, Ronald H. W. M. Derksen, Marianne C. Verhaar	2007	95
3	Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus Annals of the Rheumatic Diseases ·Peter E. Westerweel, Remco K.M.A.C. Luijten, Imo E. Hoefer, H A Koomans, R. H. W. M. Derksen, Marianne C. Verhaar	2007	85
4	Progenitor cells and vascular function are impaired in patients with chronic kidney disease Nephrology Dialysis Transplantation ·Kim E. Jie, М. Зайкова, Marloes W.T. Bergevoet, Peter E. Westerweel, M. Mehdi Rastmanesh, Peter J. Blankestijn, Walther H. Boer, Branko Braam, Marianne C. Verhaar	2010	70
5	End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells American Journal of Physiology-Renal Physiology ·Peter E. Westerweel, Imo E. Hoefer, Peter J. Blankestijn, Petra de Bree, Dafna J. Groeneveld, Olivia van Oostrom, Branko Braam, Hein A. Koomans, Marianne C. Verhaar	2007	68
6	Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients PLoS ONE ·Martin Teraa, Ralf W. Sprengers, Peter E. Westerweel, Hendrik Gremmels, Marie‐José Goumans, Tom Teerlink, Frans L. Moll, Marianne C. Verhaar	2013	59
7	Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy European Heart Journal ·Peter E. Westerweel, Frank L.J. Visseren, Gideon R. Hajer, Jobien K. Olijhoek, Imo E. Hoefer, Petra de Bree, Shahin Rafii, P. A. Doevendans, Marianne C. Verhaar	2008	58
8	Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus PLoS ONE ·Peter E. Westerweel, Martin Teraa, Shahin Rafii, Janneke E. Jaspers, Ian White, Andrea T. Hooper, Pieter A. Doevendans, Marianne C. Verhaar	2013	54
9	New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia Frontiers in Oncology ·Peter E. Westerweel, Peter A.W. te Boekhorst, Mark‐David Levin, Jan J. Cornelissen	2019	49
10	Endothelial progenitor cell dysfunction in rheumatic disease Nature Reviews Rheumatology ·Peter E. Westerweel, Marianne C. Verhaar	2009	44
11	Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia Haematologica ·Inge G.P. Geelen, Noortje Thielen, Jeroen J. W. M. Janssen, Mels Hoogendoorn, Tanja J.A. Roosma, Sten P. Willemsen, Otto Visser, Jan J. Cornelissen, Peter E. Westerweel	2017	42
12	CD34 ⁺ Cells Home, Proliferate, and Participate in Capillary Formation, and in Combination With CD34 ⁻ Cells Enhance Tube Formation in a 3-Dimensional Matrix Arteriosclerosis Thrombosis and Vascular Biology ·Maarten B. Rookmaaker, Marianne C. Verhaar, Cindy J.M. Loomans, Robert E. Verloop, Erna Peters, Peter E. Westerweel, Toyoaki Murohara, Frank J. T. Staal, Anton Jan van Zonneveld, Pieter Koolwijk, Ton J. Rabelink, Victor W.M. van Hinsbergh	2005	33
13	COVID-19 vaccination in patients with immune thrombocytopenia Blood Advances ·Chantal Visser, Maurice Swinkels, Erik van Werkhoven, F. Nanne Croles, H. S. Noordzij-Nooteboom, Matthijs Eefting, Suzanne Last-Koopmans, Cecile Idink, Peter E. Westerweel, Bart Santbergen, Pieter A. Jobse, Fazil Baboe, Peter A.W. te Boekhorst, Frank W.G. Leebeek, Mark‐David Levin, Marieke J. H. A. Kruip, A.J. Gerard Jansen	2021	30
14	The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach Journal of Medical Internet Research ·Geneviève I. C. G. Ector, Peter E. Westerweel, Rosella Hermens, Karin AE Braspenning, Barend Heeren, Oscar MF Vinck, Jan JM de Jong, Jeroen J. W. M. Janssen, Nicole M. A. Blijlevens	2020	28
15	Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia New England Journal of Medicine ·Floor L. F. van Baarle, Emma K. van de Weerdt, Walter J. F. M. van der Velden, Bart Ruiterkamp, Pieter R. Tuinman, Paula F. Ypma, Walter M. van den Bergh, Astrid Demandt, Emile D. Kerver, A.J. Gerard Jansen, Peter E. Westerweel, M. Sesmu Arbous, Rogier M. Determann, Walther van Mook, Mirelle Koeman, Anja BU Mäkelburg, Krijn P. van Lienden, Jan M. Binnekade, Bart J. Biemond, Alexander P. J. Vlaar	2023	26
16	Performance of idarucizumab as antidote of dabigatran in daily clinical practice EP Europace ·Sake J. van der Wall, Nienke van Rein, Bart J. F. van den Bemt, Marieke J.H.A. Kruip, Karina Meijer, L.C.J. te Boome, Tim Simmers, A. Marco Alings, Robert G Tieleman, Peter E. Westerweel, Frederikus A. Klok, Menno V. Huisman	2018	26
17	Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial Human Reproduction ·G.C.M. Graziosi, Hein W. Bruinse, Paul Reuwer, P.H. van Kessel, Peter E. Westerweel, Ben W. Mol	2005	24
18	Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism Blood ·Cindy M.M. de Jong, Marc Blondon, Cihan Ay, Andréa Buchmuller, Jan Beyer‐Westendorf, J. Biechele, Laurent Bertoletti, Giovanna Colombo, Marco Paolo Donadini, Stephan V. Hendriks, Luis Jara‐Palomares, Stephan Nopp, Pedro Ruiz‐Artacho, P. Stéphan, Cécile Tromeur, Thomas Vanassche, Peter E. Westerweel, Frederikus A. Klok	2022	22
19	Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate Research and Practice in Thrombosis and Haemostasis ·Roisin Bavalia, Rahat A. Abdoellakhan, Herm Jan M. Brinkman, Marjolein Brekelmans, Eva N. Hamulyák, Marleen Zuurveld, Barbara A. Hutten, Peter E. Westerweel, Renske H. Olie, Hugo Ten Cate, Marieke J.H.A. Kruip, Saskia Middeldorp, Karina Meijer, Michiel Coppens	2020	19
20	Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients Leukemia ·Inge G.P. Geelen, Fredrik Sandin, Noortje Thielen, Jeroen J. W. M. Janssen, Mels Hoogendoorn, Otto Visser, Jan J. Cornelissen, Martin Höglund, Peter E. Westerweel	2018	19

About Peter E. Westerweel

Peter E. Westerweel is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 80 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (32 papers), Chronic Lymphocytic Leukemia Research (23 papers), Angiogenesis and VEGF in Cancer (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). The work is most often cited by research in Genetics (323 citations), Hematology (289 citations), Internal Medicine (64 citations), Rheumatology (190 citations) and Nephrology (61 citations). Peter E. Westerweel has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Marianne C. Verhaar, Imo E. Hoefer, Hein A. Koomans, Mark‐David Levin, Jan J. Cornelissen, Jeroen Rouwkema, Ronald H. W. M. Derksen, Jan de Boer, Clemens van Blitterswijk and Jeroen J. W. M. Janssen. Their work appears in journals such as Blood, HemaSphere, European Journal Of Haematology, Research and Practice in Thrombosis and Haemostasis and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact